Compounds > n(g),n(g')-dimethyl-l-arginine
Page last updated: 2024-10-17

n(g),n(g')-dimethyl-l-arginine and Glycogen Storage Disease Type I

n(g),n(g')-dimethyl-l-arginine has been researched along with Glycogen Storage Disease Type I in 1 studies

N,N-dimethylarginine: asymmetric dimethylarginine; do not confuse with N,N'-dimethylarginine

Glycogen Storage Disease Type I: An autosomal recessive disease in which gene expression of glucose-6-phosphatase is absent, resulting in hypoglycemia due to lack of glucose production. Accumulation of glycogen in liver and kidney leads to organomegaly, particularly massive hepatomegaly. Increased concentrations of lactic acid and hyperlipidemia appear in the plasma. Clinical gout often appears in early childhood.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Kasapkara, ÇS1
Tümer, L1
Biberoglu, G1
Kasapkara, A1
Hasanoğlu, A1

Other Studies

1 other study available for n(g),n(g')-dimethyl-l-arginine and Glycogen Storage Disease Type I

ArticleYear
Asymmetric dimethylarginine (ADMA) and L-arginine levels in children with glycogen storage disease type I.
    Journal of pediatric endocrinology & metabolism : JPEM, 2013, Volume: 26, Issue:5-6

    Topics: Adolescent; Arginine; Child; Child, Preschool; Fatty Acids; Female; Glycogen Storage Disease Type I;

2013